Pfizer, Biogen Among Hundreds of US Drugmakers Calling for Abortion Pill Ruling Reversal

April 11, 2023

(Reuters) – Executives from more than 300 biotech and pharmaceutical industry companies, including Pfizer Inc (PFE.N) and Biogen Inc (BIIB.O), signed an open letter on Monday calling for reversal of a federal judge’s decision to suspend sales of the abortion pill mifepristone. (Read More)